Journey Medical (DERM) Non-Current Assets (2020 - 2026)
Journey Medical's (DERM) quarterly Non-Current Assets came in at $26.6 million in Q1 2026, down 14.23% YoY from $31.0 million in Q1 2025, and down 4.15% on a QoQ basis from $27.7 million in Q4 2025.
Journey Medical (DERM) Non-Current Assets (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Non-Current Assets data on file, last reported at $26.6 million in Q1 2026.
- Quarterly Non-Current Assets fell 14.23% year-over-year to $26.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $113.0 million (up 13.39% YoY) and the FY2025 annual result came in at $27.7 million, down 13.55% from the prior year.
- Non-Current Assets retreated to $26.6 million in Q1 2026, from $27.7 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $35.1 million in Q1 2023 to a low of $17.9 million in Q3 2024.
- A 5-year average of $26.3 million and a median of $27.7 million in 2025 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets soared 114.85% — and 2024, when it plunged 44.33%.
- Tracing DERM's Non-Current Assets over 5 years: stood at $27.5 million in 2022, then decreased by 25.79% to $20.4 million in 2023, then jumped by 57.21% to $32.1 million in 2024, then retreated by 13.55% to $27.7 million in 2025, then dropped by 4.15% to $26.6 million in 2026.
- The last three Non-Current Assets figures came in at $26.6 million (Q1 2026), $27.7 million (Q4 2025), and $28.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 2.96 Bn |
| 10 | Journey Medical | 208.68 Mn | 183.03 Mn | 12.37 Mn | 25.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.58 Mn |
| Mar 31, 2026 | 26.57 Mn |
| Dec 31, 2025 | 27.72 Mn |
| Sep 30, 2025 | 28.80 Mn |
| Jun 30, 2025 | 29.89 Mn |
| Mar 31, 2025 | 30.98 Mn |
| Dec 31, 2024 | 32.06 Mn |
| Sep 30, 2024 | 17.88 Mn |
| Jun 30, 2024 | 18.72 Mn |
| Mar 31, 2024 | 19.56 Mn |
| Dec 31, 2023 | 20.39 Mn |
| Sep 30, 2023 | 21.23 Mn |
| Jun 30, 2023 | 22.07 Mn |
| Mar 31, 2023 | 35.13 Mn |
| Dec 31, 2022 | 27.48 Mn |
| Sep 30, 2022 | 28.55 Mn |
| Jun 30, 2022 | 29.60 Mn |
| Mar 31, 2022 | 30.64 Mn |
| Dec 31, 2021 | 12.79 Mn |
| Sep 30, 2021 | 22.26 Mn |